Benjamin Kaffenberger, MD

Dermatological experts discuss challenges that are associated with the use of standard and emerging treatments in special patient population.

Experts discuss how to improve recognition and referral for rare dermatologic conditions in the ER setting.

Boni Elewski, MD, and Benjamin Kaffenberger, MD, and Carly Elston, MD, provide their clinical recommendations regarding future treatments for rare dermatological disorders.

Experts discuss spesolimab, an IL-36 inhibitor, that was recently FDA approved for treatment of GPP.

Experts discuss the use of biologics in the treatment of rare dermatologic disorders.

Dermatology experts review available treatment options for the treatment of rare dermatological disorders.

Experts discuss challenges in managing rare dermatological disorders.

Experts discuss what types of skin symptoms prompt patients to go to the emergency room.

Dermatology experts discuss why it is important to recognize dermatologic conditions correctly and how a misdiagnosis and delay of treatment can cause irreversible and unnecessary harm.

Experts discuss the typical journey of a patient with rare dermatologic conditions.

Benjamin Kaffenberger, MD, discusses the underlying pathophysiology of GPP, PPP, and SJS.

Boni Elewski, MD, and Benjamin Kaffenberger, MD, and Carly Elston, MD, reviews the symptoms that patients with generalized pustular psoriasis (GPP), palmoplantar pustulosis (PPP), acrodermatitis continua of Hallopeau, Steven-Johnson syndrome (SJS), toxic epidermal necrolysis, linear IgA bullous dermatosis (LABD), and hidradenitis suppurativa typically present with in a dermatology clinic.

Experts discuss some rare dermatological disorders that critical care physicians may see in the emergency room setting or dermatologists may see in their clinics along with the prevalence of these diseases.